HCS
BEAM icon

Himension Capital (Singapore)’s Beam Therapeutics BEAM Stock Holding History

Himension Capital (Singapore)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
36,419
-25,670
-41% -$775K 0.08% 91
2026
Q1 		$1.48M Buy
+62,089
New +$1.72M 0.11% 66

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Himension Capital (Singapore)'s BEAM Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its Beam Therapeutics (BEAM) stake by 41% in Q2 2026, selling an estimated $775K and leaving 36,419 shares worth $1.25M. The position accounts for 0.08% of the portfolio, ranked #91.

Himension Capital (Singapore) first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.48M in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Himension Capital (Singapore) held 36,419 shares of Beam Therapeutics worth $1.25M as of Q2 2026.
  • Himension Capital (Singapore) sold 25,670 Beam Therapeutics shares in Q2 2026, an estimated $775K.
  • Beam Therapeutics made up 0.08% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #91 holding.
  • Himension Capital (Singapore) first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Himension Capital (Singapore)'s Beam Therapeutics position peaked at $1.48M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.